Eighteen-month clinical safety and efficacy outcomes of sirolimus-, paclitaxel-and zotarolimus-drug eluting stents in diabetic patients undergoing percutaneous coronary intervention for complex coronary artery stenosis
Annals of the Academy of Medicine Singapore
Saved in:
Main Authors: | Chong, E., Poh, K.K., Liang, S., Hou, X.M., Tan, H.C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/126808 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical predictors of stent thrombosis in the "real world" drug-eluting stent era
by: Tin-Hay, E.L., et al.
Published: (2014) -
A novel drug-eluting stent using bioabsorbable polymer technology: Two-year follow-up of the CURAMI registry
by: Tin Hay, E., et al.
Published: (2014) -
Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: Importance of social factors in Asian patients
by: Poh, C.-L., et al.
Published: (2014) -
Treating Very Long Coronary Artery Lesions in the Contemporary Drug-Eluting-Stent Era: Single Long 48 mm Stent Versus Two Overlapping Stents Showed Comparable Clinical Outcomes
by: Sim, HW, et al.
Published: (2021) -
The REMEDEE trial: A randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent
by: Haude, M., et al.
Published: (2016)